Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Cereceda

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Plos One|July 21, 2020
The presence of Merkel cell carcinoma polyomavirus is associated with a distinct phenotype in neoplastic Merkel cell carcinoma cells and their tissue microenvironmentMaría-Dolores Mendoza, Carlos Santonja, Carmen Gonzalez-Vela, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 1, 2016
Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1Santiago Montes-Moreno, Nerea Martinez-Magunacelaya, Tomás Zecchini-Barrese, et al.
The American Journal of Surgical Pathology|November 18, 2015
CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise SpecifiedArantza Onaindia, Nerea Martínez, Santiago Montes-Moreno, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 8, 2014
NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphomaLina Odqvist, Santiago Montes-Moreno, Roxana E Sánchez-Pacheco, et al.
Oncotarget|March 22, 2016
Erratum: Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signaturesSoraya Curiel-Olmo, Almudena García-Castaño, Rebeca Vidal, et al.
Oncogene|March 20, 2021
ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancerThaidy Moreno, Beatriz Monterde, Laura González-Silva, et al.
Oncotarget|September 2, 2015
Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signaturesSoraya Curiel-Olmo, Almudena García-Castaño, Rebeca Vidal, et al.
Haematologica|January 2, 2015
Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activationArantza Onaindia, Sagrario Gómez, Miguel Piris-Villaespesa, et al.
Haematologica|August 22, 2015
Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphomaCristina Pérez, Julia González-Rincón, Arantza Onaindia, et al.
Haematologica|October 12, 2014
Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomasRebeca Manso, Socorro M Rodríguez-Pinilla, Julia González-Rincón, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Plos One|July 21, 2020
The presence of Merkel cell carcinoma polyomavirus is associated with a distinct phenotype in neoplastic Merkel cell carcinoma cells and their tissue microenvironmentMaría-Dolores Mendoza, Carlos Santonja, Carmen Gonzalez-Vela, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 1, 2016
Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1Santiago Montes-Moreno, Nerea Martinez-Magunacelaya, Tomás Zecchini-Barrese, et al.
The American Journal of Surgical Pathology|November 18, 2015
CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise SpecifiedArantza Onaindia, Nerea Martínez, Santiago Montes-Moreno, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 8, 2014
NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphomaLina Odqvist, Santiago Montes-Moreno, Roxana E Sánchez-Pacheco, et al.
Oncotarget|March 22, 2016
Erratum: Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signaturesSoraya Curiel-Olmo, Almudena García-Castaño, Rebeca Vidal, et al.
Oncogene|March 20, 2021
ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancerThaidy Moreno, Beatriz Monterde, Laura González-Silva, et al.
Oncotarget|September 2, 2015
Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signaturesSoraya Curiel-Olmo, Almudena García-Castaño, Rebeca Vidal, et al.
Haematologica|January 2, 2015
Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activationArantza Onaindia, Sagrario Gómez, Miguel Piris-Villaespesa, et al.
Haematologica|August 22, 2015
Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphomaCristina Pérez, Julia González-Rincón, Arantza Onaindia, et al.
Haematologica|October 12, 2014
Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomasRebeca Manso, Socorro M Rodríguez-Pinilla, Julia González-Rincón, et al.
Pageof 3